Clinical Trials on Advanced HCC in New Zealand
Total 1210 results
-
Geneos TherapeuticsActive, not recruitingHCCUnited States, New Zealand
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis C | Chronic Hepatitis C | HCV | CHCNew Zealand
-
Jiangsu HengRui Medicine Co., Ltd.CompletedLocally Advanced or Metastatic and Unresectable HCCUnited States, Spain, China, Taiwan, Belgium, Korea, Republic of, Italy, Hong Kong, Russian Federation, Ukraine, Turkey, Poland, Germany
-
Novartis PharmaceuticalsTerminated
-
Gilead SciencesCompleted
-
Genentech, Inc.RecruitingMelanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCCKorea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
-
Gilead SciencesCompleted
-
Concord Repatriation General HospitalRecruitingHCC | Hepatocellular CarcinomaAustralia, New Zealand
-
Boston Scientific CorporationCompletedACC/AHA/NASPE Class 1, IIa or IIb IndicationsNetherlands, Italy, United Kingdom, New Zealand
-
Gilead SciencesTerminatedAdvanced Solid TumorsUnited States, New Zealand
-
BeiGeneTerminatedAdvanced Solid TumorsAustralia, Spain, New Zealand
-
BeiGeneRecruitingSolid Tumor | Advanced Solid TumorUnited States, New Zealand, Australia, China
-
Icahn School of Medicine at Mount SinaiCompletedHCC | Hepatocellular Carcinoma | Hepatitis C | HCVUnited States
-
Gilead SciencesCompletedHCV InfectionUnited States, Germany, New Zealand
-
Chugai PharmaceuticalCompletedAdvanced or Metastatic HCCUnited States
-
Astellas Pharma IncTerminatedAdvanced Hepatocellular Carcinoma (HCC)Korea, Republic of, Belgium, United States, Hong Kong, Singapore, Taiwan, Germany, Spain, France, Italy
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI); University of California, San Diego; University... and other collaboratorsEnrolling by invitationLiver Cirrhosis | Hepatocellular Carcinoma (HCC)United States
-
Gilead SciencesCompletedHCV InfectionUnited States, New Zealand, Germany
-
BeiGeneCompletedAdvanced CancerUnited States, Taiwan, Australia, Korea, Republic of, New Zealand
-
BeiGeneRecruitingAdvanced Solid TumorChina, United States, Australia, New Zealand, Korea, Republic of
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, United States, Spain, France, Italy, Korea, Republic of, Poland
-
Dr. Emma's CorporationCompleted
-
Trek Therapeutics, PBCCompletedChronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV) | Hepatitis C Viral InfectionUnited States, New Zealand
-
MedImmune LLCActive, not recruitingAdvanced Solid TumorsUnited States, Spain, Belgium, Italy, Korea, Republic of, Canada, Australia, Hungary, United Kingdom, France, New Zealand
-
Gilead SciencesCompletedChronic HCV InfectionBelgium, Austria, New Zealand, United Kingdom, Germany, Spain, Netherlands, France, Switzerland, Canada, Australia, Italy
-
AstraZenecaTerminatedCancer | Advanced Solid Tumors | Advanced Solid MalignanciesUnited States
-
Massachusetts General HospitalCompletedAdvanced CancerUnited States
-
Memorial Sloan Kettering Cancer CenterPeter MacCallum Cancer Centre, Australia; Fordham University; Calvary Hospital...Completed
-
Memorial Sloan Kettering Cancer CenterArray BioPharmaCompletedAdvanced BRAF Mutant CancersUnited States
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid TumorsChina, United States, Australia, Canada, Chile, Israel, Japan, Korea, Republic of, Panama, Poland, Spain, Switzerland, Turkey, New Zealand, Taiwan
-
LaNova Medicines LimitedTerminated
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; The New School for Social Research and other collaboratorsActive, not recruitingAdvanced CancerUnited States
-
CStone PharmaceuticalsCompleted
-
Icahn School of Medicine at Mount SinaiCompletedHCC | Hepatocellular CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterUConn HealthActive, not recruitingAdvanced CancerUnited States
-
Center for International Blood and Marrow Transplant...Patient-Centered Outcomes Research Institute; National Marrow Donor ProgramCompletedAdult Hematopoietic Cell Transplant (HCT) Survivors 1-2 Yrs Post Most Recent HCTUnited States
-
Memorial Sloan Kettering Cancer CenterThe City College of New York; Queens Cancer Center of Queens Hospital; New York... and other collaboratorsRecruitingAdvanced CancerUnited States
-
Codiak BioSciencesTerminatedAdvanced Hepatocellular Carcinoma (HCC) | Gastric Cancer Metastatic to Liver | Colorectal Cancer Metastatic to LiverUnited States
-
Adlai Nortye Biopharma Co., Ltd.RecruitingLocally Advanced Solid TumorUnited States
-
Sorrento Therapeutics, Inc.Not yet recruitingAdvanced Solid TumorUnited States
-
Altor BioScienceNational Cancer Institute (NCI)CompletedAdvanced Solid TumorsUnited States
-
Suzhou Kintor Pharmaceutical Inc,Active, not recruitingHCC | Hepatocellular CarcinomaUnited States
-
Yale UniversityCelgene CorporationTerminatedAdvanced Solid CancersUnited States
-
Yale UniversityAgennixCompletedAdvanced CancersUnited States
-
Repare TherapeuticsRecruiting
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Fordham UniversityCompletedAdvanced Solid Tumor DiseasesUnited States
-
Novartis PharmaceuticalsRecruitingAdvanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12-mutant NSCLC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,MelanomaNetherlands, Korea, Republic of, Spain, Taiwan, Japan, Italy, Canada, United States, Singapore
-
MedImmune LLCCompletedAdvanced MalignanciesUnited States
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1United States